Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/22/15  and contains information from public web pages and contributions from the ZoomInfo community.

Sir Adrian P. Bird CBE

Wrong Sir Adrian P. Bird CBE?

Trustee, Scientific Advisor, Buch...

Phone: +44 *** *** ****  HQ Phone
Email: a***@***.uk
The University of Edinburgh
Teviot Place
Edinburgh , Edinburgh EH8 9AG
United Kingdom

Company Description: Established in 1583, the University of Edinburgh is one of the UK's most important and historic Higher Education institutions. World renowned for its research and...   more

Employment History

Board Memberships and Affiliations


  • PhD
  • University of Edinburgh
  • University of Sussex
  • Ph.D.
  • Ph.D
  • Ph.D.
198 Total References
Web References
Leadership | Rett Syndrome Research Trust, 22 Jan 2015 [cached]
Sir Adrian P. Bird, Ph.D. Professor of Genetics, University of Edinburgh
Sir Adrian P. Bird, Ph.D. Professor of Genetics, University of Edinburgh
Adrian Bird | Rett Syndrome Research Trust, 22 Jan 2015 [cached]
Sir Adrian P. Bird, Ph.D.
Adrian P. Bird, Ph.D.
Adrian P. Bird, Ph.D.
Trustee, Scientific Advisor Buchanan Professor of Genetics, University of Edinburgh
Adrian P. Bird, Ph.D. has been a trustee of RSRT since the inception of the organization. He is the world's leading expert in the gene MECP2, which causes Rett Syndrome when mutated. His lab discovered the MeCP2 protein in the early 1990s and currently studies the structure and function of the mammalian genome and in particular the role of DNA methylation, a fundamental mechanism controlling gene expression.
In February of 2007 Prof. Bird published the landmark paper in Science establishing the principle of reversibility of Rett symptoms in mice, providing the proof-of principle which suggests reversal may be possible in humans.
Prof. Bird became Buchanan Professor of Genetics at the University of Edinburgh in 1990. There he played a prominent role in setting up the Wellcome Trust Centre for Cell Biology, where he was Director from 1999 to 2011. Dr. Bird was a Governor of the Wellcome Trust, the world's largest medical research charity, from 2000 to 2010. In April of 2007 he was appointed Deputy Chairman and for three years oversaw assets totaling more than $27 billion.
Prof. Bird is also a trustee of Cancer Research UK and the Kirkhouse Trust. He serves on the editorial boards of Molecular and Cellular Biology and Molecular Cell. He is past Chairman of the Scientific Advisory Board for the Rett Syndrome Research Foundation, co-founded by RSRT Executive Director Monica Coenraads in 1999.
Prof. Bird studied at the University of Sussex and the University of Edinburgh. He has received numerous awards and honors, including the prestigious Howard Hughes International Fellowship, the Louis-Jeantet Prize for Medicine and the Gabor Medal of the Royal Society. He is a Fellow of the Royal Societies of London and Edinburgh and of the Academy of Medical Sciences.
In March 2011 Prof. Bird was awarded a Gairdner Foundation prize, one of the most prestigious medical honors in the world, for his discoveries in the field of DNA methylation and its role in gene expression. In 2014 he received the BBVA Foundation Frontiers of Knowledge Prize in Biomedicine.
In 2014 Professor Bird received a Knighthood for his services to science.
OAARSN Autism News Bulletin, 1 July 2006, 27 July 2014 [cached]
New research from the lab of Adrian Bird, a molecular geneticist at the University of Edinburgh, Scotland, reveals that abnormally high levels of a protein called Uqcrc1 in the brains of mouse models of Rett Syndrome cause mitochondria--the cells' powerhouses--to work overtime. "This is the first time a mitochondrial gene has been linked to Rett Syndrome," says Dr Bird. Co-author Skirmantas Kriaucionis, now at Rockefeller University in New York City, hopes the finding will lead to treatments for the disorder. "Knowledge of specific physiological defects will, in the future, provide targets for therapeutic intervention," he adds.
Our people, 28 Dec 2014 [cached]
It is difficult to over-estimate Monica's impact in catapulting Rett Syndrome research to the forefront of bio-medical research.' -Adrian P. Bird, Ph.D, RSRT Trustee.
MeCP2 Goes Global - Redefining the Function of the Rett Syndrome Protein | Rett Syndrome Research Trust, 25 Feb 2010 [cached]
The discovery of MeCP2's global reach was made in the laboratory of Adrian Bird, Ph.D. of the University of Edinburgh. Bird's seminal contributions in the Rett Syndrome field include cloning the MeCP2 protein in the early 1990's and the dramatic reversal of severe symptoms in fully mature mice models of the disease published in Science in 2007. He is a Trustee and Scientific Advisor of the Rett Syndrome Research Trust, a nonprofit organization intensively focused on the development of treatments and cures for Rett Syndrome and related MECP2 disorders.
This idea now needs to be tested by further work," said Professor Bird.
For an in-depth interview with Adrian Bird please visit the RSRT Blog,
Other People with the name "Bird":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.